They're Marketing Prescription Medications to Our Children in Our Schools By Levine & Slavit PLLC on August 27, 2008

Advocates for children are upset that Alloy Media and Marketing has run ads for prescription drugs from its Channel One website. Channel One provides free news and original programming to about 10,000 middle and high schools. Channel One is, in the opinion of many, a controversial in-school news program that makes viewing ads a compulsory part of the school day for grades six through twelve. One of Channel Ones drug ads links to, a kid-targeted website created by the pharmaceutical company sanofi-aventis to promote BenzaClin, a prescription drug for acne. The website features actor Cody Linley, who introduces himself as one of the stars of Hannah Montana, which airs on the Disney channel and is among the most popular television programs for children. As part of its user agreement with schools, Channel One has pledged not to market prescription drugs to its young audience. Yet ads for the prescription acne medications Differin and BenzaClin ran on the Channel One website for at least one week in July. In August, an ad for the prescription drug BenzaClin was back on Channel One's web site. Channel One has allowed this ad to very deceptive. There is no "advertisement" labeling above the "" banner. If Channel One told kids it was an ad that was going to take them off the Channel One web site straight to the drug company's site, then many kids might not click on it. By having users click on the ad, the drug company will know how many young people come to their web site from Critics complain that Channel One has a captive audience that should not be subjected to product manufacturer's advertisements, particularly ads that tell kids there are simple answers to problems - all you need to do is buy a product and your problem is gone. Inappropriate advertising by the pharmaceutical industry is, of course, not limited to children's advertising. The industry has been criticized for employing tactics such as direct to consumer advertising of the cypher stent, and "ghostwriting", where the drug-maker paid academic scientists to take credit for research articles prepared by company-hired medical writers. Legislation to curb the influence of these ads has been introduced in New York State and considered by the U.S. Senate. If you or someone close to you has been injured or killed by a product that was not properly manufactured, designed or labeled, contact the personal injury lawyers at Levine & Slavit for their help. The personal injury lawyers at Levine & Slavit have decades of experience handling personal injury claims including those involving dangerous and defective products . For 50 years spanning 3 generations, we have obtained results for satisfied clients.We have offices in Manhattan and Long Island, handling cases in New York City, the Bronx, Brooklyn, Queens and surrounding areas. To learn more, please watch our videos.

Related to This

Levine & Slavit, PLLC Logo

Levine & Slavit, PLLC

The law firm of Levine & Slavit, PLLC has served clients in Long Island and the Greater New York City-area since 1957. We are a team of personal injury and wrongful death lawyers who work tirelessly for victims' rights. Our team is licensed and affiliated with the:

  • New York State Bar Association
  • New Jersey Board of Bar Examiners
  • Florida Board of Bar Examiners
  • U.S. District Court Eastern District of New York
  • U.S. District Court Southern District of New York

Please contact our practice online for a free consultation or call (212) 687-2777 to speak to an attorney today. 

Contact Us Today

Rate, Review & Explore

Social Accounts Sprite
Google map image of our location in 60 E 42nd St Ste 2101 New York, NY

Manhattan Office

60 E 42nd St
Ste 2101
New York, NY 10165

Open Today 8:30am - 5:00pm

By Appointment Only

Google map image of our location in 350 Willis Ave Ste 100 Long Island, NY

Mineola Office

350 Willis Ave
Ste 100
Long Island, NY 11501

Open Today 9:00am - 5:00pm

By Appointment Only

(212) 687-2777 Send a message